Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Am J Psychiatry

Retrieve available abstracts of 76 articles:
HTML format
Text format



Single Articles


    September 2017
  1. LEVITT JJ, Nestor PG, Levin L, Pelavin P, et al
    Reduced Structural Connectivity in Frontostriatal White Matter Tracts in the Associative Loop in Schizophrenia.
    Am J Psychiatry. 2017 Sep 15:appiajp201716091046.
    PubMed     Text format     Abstract available


    August 2017
  2. SANDOVAL LR, Torous J, Keshavan MS
    Smartphones for Smarter Care? Self-Management in Schizophrenia.
    Am J Psychiatry. 2017;174:725-728.
    PubMed     Text format    


    July 2017
  3. DAVIDSON M, Saoud J, Staner C, Noel N, et al
    Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201717010122.
    PubMed     Text format     Abstract available


  4. BASSETT AS, Lowther C, Merico D, Costain G, et al
    Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2017 Jul 28:appiajp201716121417.
    PubMed     Text format     Abstract available


  5. WIMBERLEY T, MacCabe JH, Laursen TM, Sorensen HJ, et al
    Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201716091097.
    PubMed     Text format     Abstract available


  6. ANDREASSEN OA
    Diabetes and Schizophrenia-New Findings for an Old Puzzle.
    Am J Psychiatry. 2017;174:616-617.
    PubMed     Text format    


  7. PHILIP NS, Nelson BG, Frohlich F, Lim KO, et al
    Low-Intensity Transcranial Current Stimulation in Psychiatry.
    Am J Psychiatry. 2017;174:628-639.
    PubMed     Text format     Abstract available


  8. SHARMA A, Wolf DH, Ciric R, Kable JW, et al
    Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study.
    Am J Psychiatry. 2017;174:657-666.
    PubMed     Text format     Abstract available


    June 2017
  9. COYLE JT
    Cortical Pyramidal Neurons Show a Selective Loss of New Synapses in Chronic Schizophrenia.
    Am J Psychiatry. 2017;174:510-511.
    PubMed     Text format    


    May 2017
  10. LEUCHT S, Leucht C, Huhn M, Chaimani A, et al
    Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
    Am J Psychiatry. 2017 May 25:appiajp201716121358.
    PubMed     Text format     Abstract available


  11. GOFF DC, Falkai P, Fleischhacker WW, Girgis RR, et al
    The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.
    Am J Psychiatry. 2017 May 5:appiajp201716091016.
    PubMed     Text format     Abstract available


  12. HORVITZ-LENNON M, Mattke S, Predmore Z, Howes OD, et al
    The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia.
    Am J Psychiatry. 2017;174:421-426.
    PubMed     Text format    


  13. NAKIMULI-MPUNGU E
    Our Most Troubling Madness: Case Studies in Schizophrenia Across Culturesedited by T.M. Luhrmann and Jocelyn Marrow. Oakland, University of California Press, 2016, 304 pp., $29.95 (paperback).
    Am J Psychiatry. 2017;174:490.
    PubMed     Text format    


  14. HAUSER RA, Factor SA, Marder SR, Knesevich MA, et al
    KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Am J Psychiatry. 2017;174:476-484.
    PubMed     Text format     Abstract available


    April 2017
  15. ROSENHECK RA, Estroff SE, Sint K, Lin H, et al
    Incomes and Outcomes: Social Security Disability Benefits in First-Episode Psychosis.
    Am J Psychiatry. 2017 Apr 21:appiajp201716111273.
    PubMed     Text format     Abstract available


  16. LAVRETSKY H
    Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.
    Am J Psychiatry. 2017;174:307-308.
    PubMed     Text format    


    March 2017
  17. MACDONALD ML, Alhassan J, Newman JT, Richard M, et al
    Selective Loss of Smaller Spines in Schizophrenia.
    Am J Psychiatry. 2017 Mar 31:appiajp201716070814.
    PubMed     Text format     Abstract available


  18. PATERSON C, Wang Y, Hyde TM, Weinberger DR, et al
    Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Am J Psychiatry. 2017;174:256-265.
    PubMed     Text format     Abstract available


    February 2017
  19. NIEMELA S, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, et al
    Data Selection Importance in the Study of the Association Between Maternal Smoking During Pregnancy and Schizophrenia: Response to Meier et al.
    Am J Psychiatry. 2017;174:188.
    PubMed     Text format    


  20. ESSOCK SM
    When Social and Environmental Adversity Causes Schizophrenia.
    Am J Psychiatry. 2017;174:89-90.
    PubMed     Text format    


  21. MEIER SM, Mors O, Parner E
    Familial Confounding of the Association Between Maternal Smoking During Pregnancy and Schizophrenia.
    Am J Psychiatry. 2017;174:187.
    PubMed     Text format    


    January 2017
  22. RAJKUMAR AP, Horsdal HT, Wimberley T, Cohen D, et al
    Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
    Am J Psychiatry. 2017 Jan 20:appiajp201616040442.
    PubMed     Text format     Abstract available


    December 2016
  23. CROPLEY VL, Klauser P, Lenroot RK, Bruggemann J, et al
    Accelerated Gray and White Matter Deterioration With Age in Schizophrenia.
    Am J Psychiatry. 2016 Dec 6:appiajp201616050610.
    PubMed     Text format     Abstract available


  24. HOWES OD, McCutcheon R, Agid O, de Bartolomeis A, et al
    Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
    Am J Psychiatry. 2016 Dec 6:appiajp201616050503.
    PubMed     Text format     Abstract available


    November 2016
  25. BARRERA A
    Self Psychology and Psychosis: The Development of the Self During Intensive Psychotherapy of Schizophrenia and Other Psychosesby David Garfield and Ira Steinman. London, Karnac, 2015, 208 pp., $35.76 (paperback).
    Am J Psychiatry. 2016;173:1152-1153.
    PubMed     Text format    


    October 2016
  26. KIRKBRIDE JB, Hameed Y, Ankireddypalli G, Ioannidis K, et al
    The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study.
    Am J Psychiatry. 2016 Oct 24:appiajp201616010103.
    PubMed     Text format     Abstract available


  27. KELLEHER I, Cannon M
    Putting Psychosis in Its Place.
    Am J Psychiatry. 2016;173:951-952.
    PubMed     Text format    


  28. CARPENTER WT
    Early Detection of Psychosis Vulnerability: Progress, Opportunity, and Caution.
    Am J Psychiatry. 2016;173:949-950.
    PubMed     Text format    


    September 2016
  29. BERGINK V, Rasgon N, Wisner KL
    Postpartum Psychosis: Madness, Mania, and Melancholia in Motherhood.
    Am J Psychiatry. 2016 Sep 9:appiajp201616040454.
    PubMed     Text format     Abstract available


  30. HAFIZI S, Tseng HH, Rao N, Selvanathan T, et al
    Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.
    Am J Psychiatry. 2016 Sep 9:appiajp201616020171.
    PubMed     Text format     Abstract available


    August 2016
  31. DATTA D, Arion D, Roman KM, Volk DW, et al
    Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.
    Am J Psychiatry. 2016 Aug 13:appiajp201616020204.
    PubMed     Text format     Abstract available


  32. NEUHAUS AH
    Importance of Control Biotypes to Distinguish Distinct Psychosis Biotypes.
    Am J Psychiatry. 2016;173:838.
    PubMed     Text format    


  33. CLEMENTZ BA
    Challenges Facing the Identification of Neurobiologically Distinct Psychosis Subtypes: Response to Neuhaus.
    Am J Psychiatry. 2016;173:838-9.
    PubMed     Text format    


  34. LAURSEN TM, McGrath JJ
    The Strange Case of Smoking and Schizophrenia-The Epidemiology Detectives Are on the Trail.
    Am J Psychiatry. 2016;173:757-8.
    PubMed     Text format    


    July 2016
  35. CHUNG DW, Fish KN, Lewis DA
    Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.
    Am J Psychiatry. 2016 Jul 22:appiajp201616010025.
    PubMed     Text format     Abstract available


  36. DE LA FUENTE-SANDOVAL C
    Potential Regional Differences in GABA Levels in Patients With Psychosis Compared With Control Subjects.
    Am J Psychiatry. 2016;173:734.
    PubMed     Text format    


  37. MARENCO S
    Response to de la Fuente-Sandoval: Challenges Measuring GABA Levels in Patients With Psychosis.
    Am J Psychiatry. 2016;173:734-5.
    PubMed     Text format    


  38. SARPAL DK, Lencz T, Malhotra AK
    In Support of Neuroimaging Biomarkers of Treatment Response in First-Episode Schizophrenia.
    Am J Psychiatry. 2016;173:732-3.
    PubMed     Text format    


  39. CARRION RE, Cornblatt BA, Burton CZ, Tso IF, et al
    Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Am J Psychiatry. 2016 Jul 1:appiajp201615121565.
    PubMed     Text format     Abstract available


  40. CANNON TD, Yu C, Addington J, Bearden CE, et al
    An Individualized Risk Calculator for Research in Prodromal Psychosis.
    Am J Psychiatry. 2016 Jul 1:appiajp201615070890.
    PubMed     Text format     Abstract available


    June 2016
  41. HELFER B, Samara MT, Huhn M, Klupp E, et al
    Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2016 Jun 10:appiajp201615081035.
    PubMed     Text format     Abstract available


  42. ROBINSON DG
    Early Mortality Among People With Schizophrenia.
    Am J Psychiatry. 2016;173:554-5.
    PubMed     Text format    


    May 2016
  43. NIEMELA S, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, et al
    Prenatal Nicotine Exposure and Risk of Schizophrenia Among Offspring in a National Birth Cohort.
    Am J Psychiatry. 2016 May 24:appiajp201615060800.
    PubMed     Text format     Abstract available


  44. REUS VI, Fochtmann LJ, Eyler AE, Hilty DM, et al
    The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Am J Psychiatry. 2016;173:543-6.
    PubMed     Text format    


  45. BLOOMFIELD PS, Howes OD, Turkheimer F, Selvaraj S, et al
    Response to Narendran and Frankle: The Interpretation of PET Microglial Imaging in Schizophrenia.
    Am J Psychiatry. 2016;173:537-8.
    PubMed     Text format    


  46. NARENDRAN R, Frankle WG
    Comment on Analyses and Conclusions of "Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study".
    Am J Psychiatry. 2016;173:536-7.
    PubMed     Text format    


  47. MALASPINA D
    Searching for the Seeds of Psychosis.
    Am J Psychiatry. 2016;173:450-1.
    PubMed     Text format    


  48. KEGELES LS
    Brain GABA Function and Psychosis.
    Am J Psychiatry. 2016;173:448-9.
    PubMed     Text format    


    April 2016
  49. MANRIQUE-GARCIA E, Ponce de Leon A, Dalman C, Andreasson S, et al
    Cannabis, Psychosis, and Mortality: A Cohort Study of 50,373 Swedish Men.
    Am J Psychiatry. 2016 Apr 22:appiajp201614050637.
    PubMed     Text format     Abstract available


  50. CADENHEAD KS, Mirzakhanian H
    A Case of Attenuated Psychosis Syndrome: A Broad Differential Diagnosis Requires Broad-Spectrum Treatment.
    Am J Psychiatry. 2016;173:321-9.
    PubMed     Text format    


  51. JAVITT DC
    Biotypes in Psychosis: Has the RDoC Era Arrived?
    Am J Psychiatry. 2016;173:313-4.
    PubMed     Text format    


    March 2016
  52. HAIG GM, Bain EE, Robieson WZ, Baker JD, et al
    A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective alpha7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia.
    Am J Psychiatry. 2016 Mar 4:appiajp201515010093.
    PubMed     Text format     Abstract available


    February 2016
  53. SCHNACK HG, van Haren NE, Nieuwenhuis M, Hulshoff Pol HE, et al
    Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study.
    Am J Psychiatry. 2016 Feb 26:appiajp201515070922.
    PubMed     Text format     Abstract available


  54. MARQUES TR, Natesan S, Niccolini F, Politis M, et al
    Phosphodiesterase 10A in Schizophrenia: A PET Study Using [C]IMA107.
    Am J Psychiatry. 2016 Feb 19:appiajp201515040518.
    PubMed     Text format     Abstract available


  55. MARDER SR
    Community Evidence of Clozapine's Effectiveness.
    Am J Psychiatry. 2016;173:103-4.
    PubMed     Text format    


    January 2016
  56. MARENCO S, Meyer C, Kuo S, van der Veen JW, et al
    Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings.
    Am J Psychiatry. 2016 Jan 22:appiajp201515020190.
    PubMed     Text format     Abstract available


  57. LAHTI AC
    Making Progress Toward Individualized Medicine in the Treatment of Psychosis.
    Am J Psychiatry. 2016;173:5-7.
    PubMed     Text format    


  58. CANNON TD
    Microglial Activation and the Onset of Psychosis.
    Am J Psychiatry. 2016;173:3-4.
    PubMed     Text format    


  59. SARPAL DK, Argyelan M, Robinson DG, Szeszko PR, et al
    Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.
    Am J Psychiatry. 2016;173:69-77.
    PubMed     Text format     Abstract available


    December 2015
  60. ALLEN P, Chaddock CA, Egerton A, Howes OD, et al
    Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis.
    Am J Psychiatry. 2015 Dec 18:appiajp201515040485.
    PubMed     Text format     Abstract available


  61. TIIHONEN J, Mittendorfer-Rutz E, Torniainen M, Alexanderson K, et al
    Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.
    Am J Psychiatry. 2015 Dec 7:appiajp201515050618.
    PubMed     Text format     Abstract available


  62. CLEMENTZ BA, Sweeney JA, Hamm JP, Ivleva EI, et al
    Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.
    Am J Psychiatry. 2015 Dec 7:appiajp201514091200.
    PubMed     Text format     Abstract available


  63. GONG Q, Lui S, Sweeney JA
    A Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment.
    Am J Psychiatry. 2015 Dec 1:appiajp201515050641.
    PubMed     Text format     Abstract available


  64. THORNTON AE, Procyshyn RM, Barr AM, MacEwan GW, et al
    Cognition and Plasma Ratio of Clozapine to N-desmethylclozapine in Patients With Clozapine-Resistant Schizophrenia.
    Am J Psychiatry. 2015;172:1259.
    PubMed     Text format    


  65. RAJJI TK
    Response to Thornton et al.
    Am J Psychiatry. 2015;172:1259-60.
    PubMed     Text format    


    November 2015
  66. ABI-DARGHAM A
    Imaging the "GABA Shift" in Schizophrenia.
    Am J Psychiatry. 2015;172:1062-1063.
    PubMed     Text format    


  67. CAIRNS MJ
    Circulating miRNA Biomarkers for Schizophrenia?
    Am J Psychiatry. 2015;172:1059-1061.
    PubMed     Text format    


  68. AKBARIAN S, Kundakovic M
    CHRNA7 and CHRFAM7A: Psychosis and Smoking? Blame the Neighbors!
    Am J Psychiatry. 2015;172:1054-1056.
    PubMed     Text format    


  69. HYDE TM, Bharadwaj RA
    Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia.
    Am J Psychiatry. 2015;172:1052-1053.
    PubMed     Text format    


  70. KUNII Y, Zhang W, Xu Q, Hyde TM, et al
    CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
    Am J Psychiatry. 2015;172:1122-30.
    PubMed     Text format     Abstract available


    October 2015
  71. YUNG AR
    Toward Improved Risk Prediction in Individuals at High Risk of Psychotic Disorders.
    Am J Psychiatry. 2015;172:932-3.
    PubMed     Text format    


    September 2015
  72. KORNFELD DS
    Response to Review of Shrinks: The Untold Story of Psychiatry.
    Am J Psychiatry. 2015;172:910-1.
    PubMed     Text format    


  73. DUCHARME S, Price BH, Larvie M, Dougherty DD, et al
    Clinical Approach to the Differential Diagnosis Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders.
    Am J Psychiatry. 2015;172:827-37.
    PubMed     Text format    


  74. GOFF DC
    Brexpiprazole: A New Antipsychotic Following in the Footsteps of Aripiprazole.
    Am J Psychiatry. 2015;172:820-1.
    PubMed     Text format    


  75. WEIDEN PJ
    Helping Patients With Mental Illness Get Back to Work.
    Am J Psychiatry. 2015;172:817-9.
    PubMed     Text format    


  76. MCGURK SR, Mueser KT, Xie H, Welsh J, et al
    Cognitive Enhancement Treatment for People With Mental Illness Who Do Not Respond to Supported Employment: A Randomized Controlled Trial.
    Am J Psychiatry. 2015;172:852-61.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: